Plasma apolipoprotein H limits HCV replication and associates with response to NS3 protease inhibitors-based therapy-Reference-Cited by-同舟云学术

Plasma apolipoprotein H limits HCV replication and associates with response to NS3 protease inhibitors-based therapy

Published:2015-01-23 Issue:7 Volume:35 Page:1833-1844
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:Liver Int

Author:

Sultanik Philippe¹²,Mallet Vincent¹²,Lagaye Sylvie²,Casrouge Armanda³,Dorival Céline⁴,Barthe Yoann⁴,Fontaine Hélène¹²,Hézode Christophe⁵,Mottez Estelle⁶,Bronowicki Jean-Pierre⁷,Carrat Fabrice⁴⁸,Theodorou Ioannis⁹,Abel Laurent¹⁰¹¹¹²,Gayat Etienne¹³¹⁴,Fontanet Arnaud¹⁵,Pol Stanislas¹²,Albert Matthew L.³⁶,

Affiliation:

1. Department of Hepatology, Hôpital Cochin; AP-HP; Paris France

2. INSERM U 1016, CNRS UMR 8104; Université Paris Descartes UMR-S 1016; Paris France

3. The laboratory of Dendritic Cell Biology; Departement of Immunology; Institut Pasteur; INSERM U818; Paris France

4. UMR-S 707; Université Pierre et Marie Curie-Paris 6 & INSERM; Paris France

5. Department of Hepatology and Gastroenterology; Hôpital Henri Mondor; AP-HP; Université Paris-Est; Créteil France

6. Centre for Human Immunology; Departement of Immunology; Institut Pasteur; INSERM S20; Paris France

7. Centre Hospitalier Universitaire de Nancy; Université de Lorraine; INSERM U954; Vandoeuvre-les-Nancy France

8. Department of Public Health; Hôpital Saint-Antoine; AP-HP; Paris France

9. Laboratory of Immunity and Infection; Groupe Hospitalier Pitié-Salpêtrière AP-HP; INSERM UMR-S 945; UPMC Université Paris 6; Paris France

10. Laboratory of Human Genetics of Infectious Diseases; Necker branch; INSERM U1163; Paris France

11. University Paris Descartes; Sorbonne Paris Cité; Imagine Institute; Paris France

12. Laboratory of Human Genetics of Infectious Diseases; Rockefeller branch; The Rockefeller University; New-York USA

13. Department of Anesthesiology and Critical Care Medicine - Mobile Care Unit; Hôpital Lariboisière; AP-HP; Paris France

14. Biomarkers and cardiac diseases; Hôpital Lariboisière; INSERM U942; Paris France

15. Departement of Epidemiology of Infectious Disease; Institut Pasteur; Paris France

Funder

National Agency for research on Aids and Viral Hepatitis

French Association for the Study of the Liver

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/liv.12759/fullpdf

Reference49 articles.

1. Evolving epidemiology of hepatitis C virus;Lavanchy;Clin Microbiol Infect,2011

2. Daclatasvir plus sofosbuvir for previously treated or untreated chronic HCV infection;Sulkowski;N Engl J Med,2014

3. EASL Recommendations on Treatment of Hepatitis C 2014;EASL.;J Hepatol,2014

4. Minimum costs for producing hepatitis C direct-acting antivirals for use in large-scale treatment access programs in developing countries;Hill;Clin Infect Dis,2014

5. Should we await IFN-free regimens to treat HCV genotype 1 treatment-naive patients? A cost-effectiveness analysis (ANRS 95141);Deuffic-Burban;J Hepatol,2014

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Apolipoprotein(a) inhibits hepatitis C virus entry through interaction with infectious particles;Hepatology;2017-04-28

2. Persistence of HCV in Acutely-Infected Patients Depletes C24-Ceramide and Upregulates Sphingosine and Sphinganine Serum Levels;International Journal of Molecular Sciences;2016-06-13

3. Hepatitis C virus relies on lipoproteins for its life cycle;World Journal of Gastroenterology;2016

4. Interactions between Hepatitis C Virus and the Human Apolipoprotein H Acute Phase Protein: A Tool for a Sensitive Detection of the Virus;PLOS ONE;2015-10-26